Macrophage migration inhibitory factor (MIF) signaling, which has been associated with decreased tumor survival and immune modulation,[41, 42] was identified as originating primarily from NB cells, with B lymphocytes acting as the main recipients in malignant tumors (Figure S8C, Supporting Information). This evidence concerns the gene MIF and neoplasm.